Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT02576301 |
| Title | Dose Escalation of OXi4503 as Single Agent and Combination With Cytarabine w/Subsequent Ph 2 Cohorts for AML and MDS |
| Acronym | AML |
| Recruitment | Unknown status |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | OXiGENE |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| David Geffen School of Medicine at UCLA | RECRUITING | Los Angeles | California | 90095 | United States | Details |
| University of Florida | RECRUITING | Gainesville | Florida | 32610 | United States | Details |
| University of Miami Sylvester Comprehensive Cancer Center | RECRUITING | Miami | Florida | 33136 | United States | Details |
| University of Kansas Cancer Center and Medical Pavilion | RECRUITING | Westwood | Kansas | 66205 | United States | Details |